Fungal infections, often overshadowed by bacterial threats, are developing resistance to treatments, contributing to what ...

Ilaris, which treats conditions including Still’s disease, can cause side effects such as unexpected weight gain. Learn about ...

Fosmanogepix is a first-in-class antifungal treatment candidate with a novel mechanism of action. It is available in intravenous and oral formulations and has been evaluated for efficacy and safety in ...

We’re still asking people with COVID to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.

A new report says that 13 percent of cancers are linked to bacteria or viruses. Vaccines and treatments offer powerful ...